Midgard Science

Labs / Assays & in vitro testing

Phaim

London, United Kingdom · phaim.co.uk

On your own

Free. Their own form.

Contact Phaim directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Phaim is a London-based biotechnology company developing antigen-specific immunotherapies for autoimmune disease. Its first application is Type 1 Diabetes, and its pipeline also includes psoriasis, rheumatoid arthritis, and multiple sclerosis.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Antigenic Immune Modulation (AIM) platform development

    Develops a therapeutic platform designed to cure, improve, halt, or prevent autoimmune disease by resetting immune tolerance.

  • Type 1 diabetes drug candidate development

    Develops DMX4001 as the first application of its platform for Type 1 Diabetes.

  • Preclinical study design and validation

    Has completed preclinical animal work and validated CMC processes to support scale-up for clinical studies.

  • Autoimmune biomarker development

    Maintains proprietary biomarkers to characterize type 1 diabetes risk and likely disease progression.

What they work on

Modalities
Small molecule, Antibody, ADC, Peptide
Species and models
animal study, pancreas, Antigen Presenting Cells, regulatory T cells
Assays and studies
CMC process validation
Therapeutic areas
Type 1 Diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis, autoimmune disease
Sites
London, United Kingdom
Founded
2019

Similar labs. Sai Life, Aurigene Pharmaceutical Services, Esco Aster, Porton

Found in a contract services directory. Listing built from phaim.co.uk. Work here? Claim this listing.

Phaim · Midgard Science